246 related articles for article (PubMed ID: 27519285)
1. An update on cutaneous melanoma in Turkey: evaluation of 19-year data in a single tertiary centre and review of the literature.
Baykal C; Atci T; Polat Ekinci A; Buyukbabani N
J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):236-240. PubMed ID: 27519285
[TBL] [Abstract][Full Text] [Related]
2. A retrospective multicenter evaluation of cutaneous melanomas in Turkey.
Gamsizkan M; Yilmaz I; Buyukbabani N; Demirkesen C; Demiriz M; Cetin ED; Ince U; Akalin T; Demirkan NC; Lebe B; Erdem O; Gokoz O; Sakiz D; Demireli PT; Astarci HM; Adim SB; Zemheri IE; Acikalin A; Yaman B; Aydin O; Bassorgun CI
Asian Pac J Cancer Prev; 2014; 15(23):10451-6. PubMed ID: 25556491
[TBL] [Abstract][Full Text] [Related]
3. Assessment of melanoma histotypes and associated patient related factors: basis for a predictive statistical model.
Haenssle HA; Hoffmann S; Buhl T; Emmert S; Schön MP; Bertsch HP; Rosenberger A
J Dtsch Dermatol Ges; 2015 Jan; 13(1):37-45. PubMed ID: 25640492
[TBL] [Abstract][Full Text] [Related]
4. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
Tas F; Kurul S; Camlica H; Topuz E
Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
[TBL] [Abstract][Full Text] [Related]
5. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma in Taiwan: a prognostic study of 181 cases.
Chang JW; Yeh KY; Wang CH; Yang TS; Chiang HF; Wei FC; Kuo TT; Yang CH
Melanoma Res; 2004 Dec; 14(6):537-41. PubMed ID: 15577327
[TBL] [Abstract][Full Text] [Related]
7. Characteristic features of cutaneous melanoma in a dermatology referral centre in Tehran, Iran.
Kamyab K; Kazemi S; Azimi P; Azizpour A; Ghandi N; Pirooz E; Noormohammadpour P; Mirshams-Shahshahani M; Daneshpazhooh M
Australas J Dermatol; 2017 Nov; 58(4):e228-e231. PubMed ID: 28295169
[TBL] [Abstract][Full Text] [Related]
8. Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland.
Minini R; Rohrmann S; Braun R; Korol D; Dehler S
Melanoma Res; 2017 Apr; 27(2):145-151. PubMed ID: 27926588
[TBL] [Abstract][Full Text] [Related]
9. Role of obesity on the thickness of primary cutaneous melanoma.
Skowron F; Bérard F; Balme B; Maucort-Boulch D
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):262-269. PubMed ID: 24750303
[TBL] [Abstract][Full Text] [Related]
10. [Clinical aspects and pathology of melanoma].
Panizzon RG; Guggisberg D
Ther Umsch; 1999 Jun; 56(6):302-8. PubMed ID: 10420811
[TBL] [Abstract][Full Text] [Related]
11. Thick melanoma: the challenge persists.
Murray CS; Stockton DL; Doherty VR
Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
[TBL] [Abstract][Full Text] [Related]
12. Biological behaviour of cutaneous malignant melanomas.
Søndergaard K
Pathology; 1985 Apr; 17(2):255-7. PubMed ID: 4047727
[TBL] [Abstract][Full Text] [Related]
13. Thick melanoma: the problem continues.
Tejera-Vaquerizo A; Mendiola-Fernández M; Fernández-Orland A; Herrera-Ceballos E
J Eur Acad Dermatol Venereol; 2008 May; 22(5):575-9. PubMed ID: 18081751
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Study of Malignant Melanoma at Tertiary Care Centre.
Thapa S; Ghosh A; Ghartimagar D; Prasad T; Narasimhan R; Talwar O
JNMA J Nepal Med Assoc; 2017; 56(205):132-136. PubMed ID: 28598449
[TBL] [Abstract][Full Text] [Related]
15. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
16. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2006 Sep; 155(3):561-9. PubMed ID: 16911282
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and histopathological characteristics of malignant melanoma cases seen at "Dr. Manuel Gea González" General Hospital].
Káram-Orantes M; Toussaint-Caire S; Domínguez-Cherit J; Veja-Memije E
Gac Med Mex; 2008; 144(3):219-23. PubMed ID: 18714590
[TBL] [Abstract][Full Text] [Related]
18. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
19. High density of M2-macrophages in acral lentiginous melanoma compared to superficial spreading melanoma.
Zúñiga-Castillo M; Pereira NV; Sotto MN
Histopathology; 2018 Jun; 72(7):1189-1198. PubMed ID: 29415335
[TBL] [Abstract][Full Text] [Related]
20. Histological type and biological behavior of primary cutaneous malignant melanoma. 2. An analysis of 86 cases located on so-called acral regions as plantar, palmar, and sub-/parungual areas.
Søndergaard K
Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):333-43. PubMed ID: 6415910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]